← All indications
Ventricular Remodeling
The geometric and structural changes that the HEART VENTRICLES undergo, usually following MYOCARDIAL INFARCTION. It comprises expansion of the infarct and dilatation of the healthy ventricle segments. While most prevalent in the left ventricle, it can also occur in the right ventricle.
Drugs by status
Phase 4 trials (10)
Phase 3 trials (6)
Phase 2 trials (1)
Phase 1 trials (1)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (33)
- Actelion
- R&D Cardiologie
- European Foundation for the Study of Diabetes
- Hospital Clínico Universitario de Valladolid
- American Heart Association
- Dong-A University
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Kyung Hee University
- Osaka University
- Seoul National University
- Silesian University of Medicine
- University of Dundee
- University of Glasgow
- Utrecht University
- University of Bergen
- Chonbuk National University
- University of Colorado, Denver
- University of Copenhagen
- University of Naples Frederico II
- University of Ulsan
- University of Utah
- Chungnam National University
- Gyeongsang University
- National University of Singapore
- St. Antonius Hospital, Nieuwegein
- Kyungpook University
- Polpharma
- Chonnam National University
- Sungkyunkwan University
- Ghent University
- +3 more
Organization Involved with Phase 3 Indications (10)
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Iuliu Hatieganu University of Medicine and Pharmacy
- Spanish Society of Cardiology
- Universidad Autonoma de Madrid
- University of Oslo
- University of Indonesia
- University of Sao Paulo
- Romania:The National Authority for Scientific Research
- Fondo de Investigacion Sanitaria
- Government of Singapore
Organization Involved with Phase 2 Indications (8)
Organization Involved with Phase 1 Indications (1)